Autori: Zhang Jianjun
| Naslov | A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3. (Meeting Abstract) |
| Autori | Zhang Jianjun ... Andric Zoran G ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2025), vol. 43 br. 16_SUPPL, Suppl. 16_SUPPL, str. TPS8664-TPS8664 |
| Projekat | Summit Therapeutics, Inc. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
